Send Inquiry
Send SMS
  
Call Me Free

Mydacla
Mydacla
Daclahep
Daclahep
Velasof
Velasof
Dacihep
Dacihep
Cimivir L
Cimivir L
Natdac
Natdac
Cimivir
Cimivir
Sofosbuvir 400mg & Velpatasvir 100mg
Sofosbuvir 400mg & Velpatasvir 100mg
Velpatasvir
Velpatasvir
Sofosbuvir & Velpatasvir
Sofosbuvir & Velpatasvir
Virpas
Virpas
Virso
Virso
Hepcinat LP
Hepcinat LP
sofovir
sofovir
Myhep
Myhep
Dactovin
Dactovin
Velasof Hetero
Velasof Hetero
Daclawin
Daclawin
Trust Stamp
Product Showcase
Home » Products » Hepatitis Drugs » Resof

Resof

Resof
Resof
Send Inquiry
Product Code : 22
Brand Name : Resof
Product Description
  • Brand name: Resof
  • Active Ingeridents: Sofosbuvir
  • Company Name: Dr.Reddy
  • Package: 28 Tablets
  • Strength : 400 mg

Indication:

It is used for the treatment of hepatitis Cvirus (HCV) infection. Compared to previous treatments, Sofosbuvir-based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy. Resof(Sofosbuvir) allows most patients to be treated successfully without the use of peginterferon, an injectable drug with severe side effects. that is a key component of older drug combinations for the treatment of HCV. Resof(Sofosbuvir) is used for the treatment of chronic hepatitis C, genotypes 1, 2, 3, and 4, in combination with pegylated interferon and ribavirin, or with ribavirin alone. It is also used in combination with the viral NS5a inhibitor ledipasvir in an interferon-free combination for the treatment of genotype 1 hepatitis C infection. Resof(Sofosbuvir) is also used in HCV patients with an HIV coinfection. The treatment is based on a number of clinical trials, for example the ELECTRON trial which showed that a dual interferon-free regimen of Sofosbuvir(Resof) plus ribavirin produced a 24-week post-treatment sustained virological response (SVR24) rate of 100% for previously untreated patients with HCV genotypes 2 or 3.

Mechanism of action:

Resof(Sofosbuvir) contains oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. The drug is a direct-acting antiviral agent and interferes straight with the HCV lifecycle, restraining the viral replication. It can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. The drug is available for oral use in the form of 400mg tablets.

Dosage and Administration:

The recommended daily dose of Resof(Sofosbuvir) is 400mg tablet to be taken once daily with or without food. Resof(Sofosbuvir) should be used in combination with Ribavirin or in combination with Pegylated Interferon and Ribavirin for the treatment of CHC (Chronic Hepatitis C) in adults. It is highly advisable to administer the drug under strict medical supervision and advice.

Side effects:

Adverse events associated with the use of Resof(Sofosbuvir) in combination with Ribavirin may include, but are not limited to, the following

Fatigue , headache Adverse events associated with the use of Resof(Sofosbuvir) in combination with Peginterferon Alfa and Ribavirin may include, but are not limited to, the following:

Fatigue,headache, nausea, insomnia, anemia

Precaution: Safety and efficacy have not been established in patients younger than 18 years. Consult WARNINGS section for additional precautions.

Store: Store at 25°C in a dry place.

Product Details:

Brand

Resof

Dosage Form

Tablet

Packaging Size

1x28

Packaging Type

Bottle

Strength/Dose (in mg or ml)

400mg

Pack Size

28 tabs

Product Type

Finish Product


MILLION HEALTH PHARMACEUTICALS
X


  • Contact Details
  • MILLION HEALTH PHARMACEUTICALS
  • Portion A, First Floor, Old No. 131, New No. 50, Pedariyar Koil Street, Seven Wells, Chennai - 600001, Tamil Nadu, India
  • Phone : +918068095074
Send Inquiry
Send SMS
  
Call Me Free
  • Mr. Saravanan R (Proprietor)
  • Mobile : +918068095074
MILLION HEALTH PHARMACEUTICALS All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.